Previous reports showed no evidence of ACE2 mRNA expression in platelets either from COVID-19 patients or from cultured megakaryocytes from healthy donors [6], suggesting that the internalization of SARS-CoV-2 in megakaryocytes and platelets might occur through alternative pathways. This evidence concerns the gene ACE2 and COVID-19.